Connecting patients to afforable medicines

“An estimated two billion people have no access to essential medicines”

– World Health Organization

“The global generic sterile injectables market accounted for $68.7 billion in 2019 and is estimated to be $196.2 billion by 2029 with a CAGR of 11.2% during the forecast period.”


GenerX’s mission is to provide affordable, high quality, safe, and effective generic medicines to patients through innovation and excellence.

Development / Co-Development

GenerX identifies and utilizes world class CMOs/CDMOs to develop and manufacture sterile injectable generic drug products

Licensing and Acquisitions

GenerX licenses and acquires technologies and drug product candidates to expand our pipelines

Strategic Partnerships

GenerX continuously searches for opportunities to grow and expand our business